Atlas Trials

Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression

Clinical trial NCT02229825 · COMPLETED

Trial details

NCT number
NCT02229825
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2007-02-09
Primary completion
2008-08-26
Enrollment
339

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.